Search the Newsreel

Q2 2026 Insperity Inc Earnings Call Transcript

This article provides the Q2 2026 earnings call transcript for Insperity Inc. (FRA:ASF), highlighting both positive and negative aspects of their performance. Key positives include exceeding Adjusted EPS and EBITDA guidance, strong worksite employee growth, and the successful launch of HR Scale. Negatives include …

NSP|Insperity Inc|Price:52.200|Chg%:-1.530

Insperity, Inc. $NSP Shares Sold by Bank of America Corp DE

Bank of America Corp DE significantly reduced its stake in Insperity, Inc. (NYSE:NSP) by 42% in the first quarter, selling over 976,000 shares. Despite this, institutional investors collectively hold a large majority of the company's stock, while Insperity's CEO increased his personal holdings. The …

NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance

InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates

InspireMD, Inc. (NSPR) reported a Q2 loss of $0.17 per share, outperforming the Zacks Consensus Estimate of a $0.2 loss and representing a 15% earnings surprise. The company's revenues for the quarter were $1.77 million, surpassing estimates by 7.33%, although slightly down from the …

INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More

INSPIREMD (NSPR) is set to release its Q2 2026 earnings on August 17th, with analysts forecasting revenue of $1.41 million and a loss of $0.20 per share. Recent insider trading shows more purchases than sales, while hedge fund activity indicates both increased and decreased …

InspireMD (NSPR) grows revenue 56% but flags going concern and Nasdaq risk

InspireMD, Inc. reported increased revenues for the first half of 2026, up 56.3% to $5.17 million, driven by U.S. CGuard Prime sales and international growth, despite a voluntary recall of CGuard Prime impacting quarterly revenue and gross margin. The company posted a significant net …

EARNEST Partners LLC discloses 8.1% Insperity (NSP) holding in amended 13G

EARNEST Partners, LLC has disclosed an 8.1% beneficial ownership in Insperity, Inc. (NSP) through an amended Schedule 13G filing. The investment adviser holds 3,099,996 shares, with sole voting power over 2,291,712 shares and shared voting power over 601,345 shares, and sole dispositive power over …

Inspur Digital Enterprise Schedules Board Meeting on Interim Results and Dividend

Invesco Ltd. (NSP) discloses 1.29M-share beneficial stake in Insperity

Invesco Ltd. has disclosed a beneficial ownership of 1,286,693 shares of Insperity Inc. common stock, representing 3.4% of the outstanding class. This information was reported in an amended Schedule 13G/A filing, indicating that Invesco, as a parent holding company, has sole voting power over …

Inspire Medical Systems (INSP): Soleus Capital group reports 6.7% ownership stake

Soleus Capital Master Fund, L.P. and affiliated entities have reported a 6.7% ownership stake in Inspire Medical Systems, Inc. (INSP), holding 1,931,436 shares of common stock. This beneficial ownership is based on 28,910,375 shares outstanding as of July 30, 2026, and grants shared voting …

Inspired Entertainment (NASDAQ:INSE) Stock Price Passes Below 50 Day Moving Average - Here's Why

Inspired Entertainment (INSE) insider reports extensive indirect RSU and trust holdings

Managed Account Advisors LLC (NSP) discloses 5.7% beneficial stake in Insperity

Managed Account Advisors LLC has reported a 5.7% beneficial ownership stake in Insperity, Inc. (NSP), totaling 2,186,555 shares of common stock. This disclosure, made via a Schedule 13G filing, indicates no voting power but significant dispositive power over these shares. The ownership percentage is …

AQR Capital discloses 6.44% Inspire Medical Systems (INSP) ownership on Schedule 13G

AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 6.44% in Inspire Medical Systems, Inc. (INSP) through a Schedule 13G filing. The AQR entities collectively own 1,856,800 shares, with shared voting power over 1,783,224 shares …

Inspired Entertainment: Playtech SaaS Rollout Begins As Interactive Revenue Grows 15% And Digital Expansion Accelerates

Inspired Entertainment has initiated the rollout of its Virtual Sports content via a SaaS agreement with Playtech, starting with Malta Lottery, as its Interactive business expands and shifts towards higher-margin digital operations. In Q2, Interactive revenue rose 15% year-over-year to $15.7 million, with Adjusted …

Quantinno Capital Management LP Acquires 20,535 Shares of Insperity, Inc. $NSP

Quantinno Capital Management LP increased its stake in Insperity, Inc. (NYSE:NSP) by 43.2% in the first quarter, purchasing an additional 20,535 shares to bring its total holdings to 68,101 shares valued at $1.84 million. Institutional investors now own 93.44% of the company. Insperity reported …

Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Recommendation of "Hold" by Analysts

Analysts have issued a consensus "Hold" rating for Inspire Medical Systems, Inc. (NYSE:INSP), with an average 12-month price target of $68.00. The company recently reported quarterly EPS of $0.14, surpassing expectations, and revenue of $200.6 million, although revenue declined 7.6% year over year. Institutional …

Inspire medical systems chief mfg. officer Kelly sells $57,346 in stock

Jason P. Kelly, Chief Manufacturing and Quality Officer at Inspire Medical Systems (NASDAQ:INSP), sold 963 shares of company stock for a total of $57,346. Following the sale, Mr. Kelly directly owns 18,985 shares. Despite the stock being down 36% year-to-date, InvestingPro analysis suggests the …

Inspire Medical Systems (NYSE:INSP) Insider Jason Kelly Sells 963 Shares of Stock

Inspire Medical Systems insider Jason Kelly sold 963 shares of the company's stock for approximately $57,346.65, reducing his holdings by 4.83%. The company recently reported better-than-expected quarterly earnings and revenue, but revenue was down 7.6% year-over-year. Analysts maintain a "Hold" rating on the stock …

Inspire Medical Systems (INSP) Q2 2026 Earnings Call Transcript

Inspire Medical Systems (INSP) reported Q2 2026 revenue of $200.6 million, a 7.6% decrease due to coding and reimbursement disruptions, but raised its full-year revenue guidance to $835 million to $875 million. The company launched "Project Horizon" to optimize its organizational structure and supply …

Inspirisys Solutions Q1 Results: Net profit falls 19% YoY to ₹4.28 crore

Insperity (NSP) Dropped, So What Is Behind The Latest Attention?

Insperity (NSP) is under scrutiny after its Q2 2026 earnings report, which showed a shift from a net loss to a net profit, and updated guidance for the third quarter and full year. The stock has experienced recent volatility, declining short-term but showing significant …

China Leon Inspection Schedules Board Meeting to Approve Interim Results and Consider Dividend

Price to sales ratio of Inspire Medical Systems, Inc. – HAM:2DR

This article focuses on the price to sales ratio of Inspire Medical Systems, Inc. (HAM:2DR) on the Hamburg Stock Exchange. It provides general financial overview information for the company as listed on TradingView.

Janus Henderson Group PLC Sells 548,880 Shares of Inspire Medical Systems, Inc. $INSP

5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings Call

Inspire Medical Systems (INSP) surpassed Q2 analyst expectations with improved operating income and positive cash flow, driven by better coding clarity and cost discipline. Management raised its full-year revenue and Adjusted EPS guidance, demonstrating resilience despite a year-on-year revenue decline. Analyst questions focused on …

InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set

InspireMD, Inc. will release its second quarter 2026 financial results on August 17, 2026, followed by a conference call and webcast at 8:30 a.m. ET. The company, known for its CGuard Prime carotid stent system, will discuss its financial performance and operational updates, including …

InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results

InspireMD (Nasdaq: NSPR) announced it will release its second quarter 2026 financial results on Monday, August 17, 2026. The company will host a conference call and live audio webcast at 8:30 a.m. Eastern Time to discuss the results and recent highlights. Investors can participate …

Inspire Medical Systems (INSP) Is Up 19.8% After Q2 Profit And Higher 2026 Guidance - Has The Bull Case Changed?

Inspire Medical Systems reported a swing to profit in Q2 2026 and raised its full-year 2026 revenue guidance, leading to a 19.8% stock increase. Despite this, the company faces ongoing challenges with the Inspire V rollout, marketing spend, and reimbursement policies. The article questions …

Dimensional Fund Advisors LP Trims Holdings in Inspire Medical Systems, Inc. $INSP

Dimensional Fund Advisors LP reduced its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 31.3% in the first quarter, selling over 106,000 shares but retaining a significant holding valued at $12.1 million. Despite this trimming, institutional investors collectively own 94.91% of the company. Inspire …

Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k

Insiders at InspireMD bought US$420.8k worth of stock over the last year, but despite a recent 14% stock gain, they are still down US$161k on their purchases. While there was some insider selling, the net insider activity over the year indicates more buying than …

Reinhart Partners LLC. Buys 356,365 Shares of Insperity, Inc. $NSP

Reinhart Partners LLC. increased its stake in Insperity, Inc. (NYSE:NSP) by 12.1% in the second quarter, bringing its total holding to 3.30 million shares valued at $136.5 million. This makes Insperity Reinhart Partners' 9th largest position, accounting for 3.1% of their investment portfolio. Insperity …